Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Heart Failure
100%
Cardiac Function
41%
Spatial Specificity
33%
Splicing Dysregulation
33%
Solute Carrier Family 2 Member 1
33%
Cardiovascular History
33%
Splicing Alteration
33%
Left Ventricle
33%
Ischemic Cardiomyopathy
33%
Dilated Cardiomyopathy
33%
Neurological Complications
33%
Cardiovascular Risk
33%
Direct RNA Sequencing
33%
Idiopathic PD
33%
N6-methyladenosine
33%
Anemia
33%
Memory Impairment
33%
Idiopathic Parkinson's Disease
33%
Outcome Prediction
33%
Myocardial Infarction
33%
Neurological Outcome
33%
Cerebral Performance Category
33%
Health Effects
33%
Cross-sectional Observational Study
33%
Zebrafish
33%
COVID-19
33%
Cardiac Arrest
33%
Post-COVID
33%
Duct Formation
33%
Cardiovascular Complications
33%
LEF1
33%
Quantitative PCR
31%
Parkinson's Disease
27%
SLC2A1
19%
Neurological Sequelae
19%
Splicing Event
16%
Ventricle Right
16%
Interventricular Septum
16%
Dysregulated
16%
Right Ventricle
16%
History of Cardiovascular Disease
16%
SARS-CoV-2 Infection
15%
Odds Ratio
14%
95% Confidence Interval
14%
North Pole
14%
Neurological Death
14%
Zebrafish Heart
13%
Blood Levels
13%
RNA Sequencing (RNA-seq)
13%
Large Cohort
12%
Biochemistry, Genetics and Molecular Biology
Zebra Fish
57%
RNA Sequence
41%
Real-Time Polymerase Chain Reaction
36%
RNA
33%
Alternative Splicing
33%
Solute Carrier Family
33%
Cardiac Arrest
33%
Peripheral Blood Mononuclear Cell
33%
Embryogenesis
33%
Tissue Distribution
33%
Epigenetic Modification
33%
Circadian Rhythm
33%
Epitranscriptomics
33%
N6-Methyladenosine
33%
Heart Ejection Fraction
33%
Fat Mass
33%
Rat
27%
Cortisol
26%
Melatonin
26%
Long Non-Coding RNA
25%
Eukaryote
22%
DNA Methylation
22%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
RNA Sequencing
16%
RNA-binding Protein
16%
Splicing Defect
16%
Antisense
16%
Non-Coding RNA
16%
Lymphoid Enhancer-Binding Factor 1
16%
RNA Modification
16%
Molecular Mechanism
16%
Monocyte
16%
Chromatography
16%
Demethylase
16%
Reperfusion
16%
Mass Spectrometry
16%
Green Fluorescent Protein
13%
Troponin T
13%
Cardiac Troponin
13%
Gene Expression
12%
Upregulation
12%
Tissue Specificity
11%
Genetic Transcription
11%
Cell Fate Determination
11%
Embryonic Stem Cell
11%
Fetus Development
11%
X Chromosome
11%
Biological Phenomena and Functions Concerning the Entire Organism
11%
Adenine
11%
5-Methylcytosine
11%
Medicine and Dentistry
Congestive Heart Failure
100%
Cardiovascular Disease
52%
Heart Function
38%
Cardiovascular System
37%
Ischemic Cardiomyopathy
35%
Heart Arrest
33%
Parkinson's Disease
33%
Dilated Cardiomyopathy
33%
Glucose Transporter 1
33%
Observational Study
33%
RNA Sequence
33%
Circadian Rhythm
33%
Anemia
33%
Lymphoid Enhancer Factor 1
33%
COVID-19
33%
Neurological Complication
33%
Cardiac Regeneration
33%
Left Ventricle
22%
Sequela
22%
Biological Marker
18%
Phenylhydrazine
17%
Real-Time Polymerase Chain Reaction
14%
Odds Ratio
14%
Diseases
12%
Gene Expression
12%
Brain Injury
11%
Right Ventricle
11%
Interventricular Septum
11%
Alternative RNA Splicing
11%
Diastole
11%
Cardiac Catheterization
11%
Hydrocortisone
9%
Myelodysplastic Syndrome
9%
Melatonin
9%
Unified Parkinson's Disease Rating Scale
9%
Dysautonomia
9%
COVID-19 Diagnosis
7%
Disease Severity
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Infection
7%
Cytotoxic T-Cell
7%
Comorbidity
6%
Upregulation
5%
Etiology
5%
Blood Brain Barrier
5%
Pathophysiology
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Brain Death
5%
Heart Development
5%
Morbidity
5%
